A study of incretin secretion and incretin effect in the Japanese

A study of incretin secretion and incretin effect in the Japanese - Incretin secretion and incretin effect in the Japanese

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000002878

Enrollment

Registered

2010-06-01

Start date

2009-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects who can gave written consent by herself or himself

Exclusion criteria

Exclusion criteria: 1. Subjects who have severe hepatic or renal disease. 2. Subjects who have severe heart or pulmonary disease. 3. Subjects who have severe pancreatic disease. 4. Subjects who have severe diabetic complications. 5. Subjects who have malignant cancers.

Design outcomes

Primary

Measure	Time frame
Plasma GIP and GLP-1 concentrations during oral glucose tolerance test, mixed meal test, and isoglycemic glucose clamp test. Incretin effect calculated from plasma insulin and other factors during glucose tolerance test, mixed meal test, and isoglycemic glucose clamp test.	—

Countries

Japan

Contacts

Public ContactAkihiro Hamasaki

Graduate School of Medicine, Kyoto University Department of Diabetes and Clinical Nutrition

075-751-3560

Outcome results